CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 170 enrolled
Drug / intervention
Antidepressants through Texas Medication Algorithm (TMA) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00742573
NCT00742573Phase 2Completed
CompareCT.gov

Improving the Effectiveness of Treatment for Depression in Hispanics

New York State Psychiatric Institute·interventional·Posted Aug 27, 2008·Updated Mar 3, 2020

In Brief

A Phase 2 clinical trial evaluating Antidepressants through Texas Medication Algorithm (TMA) and Brief Interpersonal Psychotherapy (IPT-B) for Major Depressive Disorder. Completed, enrolled 170 participants across 1 site.

Detailed Summary

This study will determine whether combination treatment driven by patient choice is better than standardized medication treatment at retaining and improving Hispanic patients with major depressive disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMajor Depressive Disorder
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

Phase 2CompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 27, 2008
Enrollment StartAug 1, 2008
Primary CompletionJan 10, 2014
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 17.8 years ago

Interventions

Antidepressants through Texas Medication Algorithm (TMA)drug

Treatment with medication will follow the TMA for depression. Antidepressant medications may include any of the following: citalopram, escitalopram, paroxetine, sertraline, venlafaxine XR, bupropion SR, duloxetine, nortriptyline, and mirtazapine.

Brief Interpersonal Psychotherapy (IPT-B)behavioral

IPT-B consists of twelve 50-minute sessions, divided into three phases, focusing on an interpersonal problem or problems.